Michael J. Brown, Chief Executive Officer at Monopar Therapeutics (MNPR), sold 33,334 shares at $35.00 ($1.2M) on 2025-04-02, disclosed to the SEC on 2025-04-04.
Seasonal sale ($1.2M) by Chief Executive Officer — this insider has traded MNPR in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| RRBI | BUY | 2024-05-17 | $43K | — | Filing → |
| RRBI | BUY | 2024-05-15 | $29K | — | Filing → |
| RRBI | BUY | 2024-02-14 | $44K | — | Filing → |